Leaving GSK Pro

You are leaving GSK Pro to visit a separate website not associated with GSK Pro, a portal for US Healthcare Professionals.There are website links to third-party sites on GSK Pro. GSK is not responsible for content on third-party websites.

Continue

Cancel

hyperlink,10000

I HAVE EGPA AND A WAY FORWARD
Is NUCALA right for your patient

NUCALA is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).

NUCALA—the first and only FDA-approved treatment for eosinophilic granulomatosis with polyangiitis (formerly known as Churg-Strauss syndrome)1

Reference: 1. Jennette JC, Falk RJ, Bacon A, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1-11.

https://gskpro-com-preprod-cf5.gdsgsk.com/en-us/products/nucala/about/,1000